Company: Nutrisystem, Inc.
Kaskela Law LLC is investigating Nutrisystem, Inc. (“Nutrisystem” or the “Company”) (Nasdaq: NTRI) on behalf of the Company’s shareholders concerning the sale of Nutrisystem to Tivity Health, Inc. (Nasdaq: TVTY). Under the terms of the proposed transaction, Nutrisystem shareholders are expected to receive $38.75 in cash and 0.2141 Tivity Health shares for each share of Nutrisystem common stock.
The investigation seeks to determine whether the proposed transaction undervalues Nutrisystem’s shares, and whether Nutrisystem’s Board of Directors violated the securities laws and/or breached their fiduciary duties to stockholders by (i) failing to conduct a fair sales process of the Company and (ii) failing to disclose all material information to stockholders in connection with the proposed transaction with Tivity Health.
Nutrisystem stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (888) 715 – 1740 to discuss this investigation and their legal rights and options, or complete the information form on this page to receive additional information.